Cycurion, Inc. (CYCUW)
Cycurion, Inc. (CYCUW)
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net loss | -2,561,786 | -5,280,167 | -18,778,917 | NaN |
| Stock-based compensation | 315,833 | 804,424 | -7,440,334 | 10,534,777 |
| Stock-based compensation - business combination related | 0 | 0 | 9,521,734 | NaN |
| Amortization of debt discount | 1,187 | 7,665 | 21,394 | 213,036 |
| Depreciation of property and equipment | 0 | 0 | 16,832 | 3,489 |
| Amortization of software development costs | 0 | 0 | 25,000 | NaN |
| Gain on debt settlement, net | 0 | -28,504 | 2,016,469 | -766,330 |
| Finance expense | 0 | 0 | 0 | 100,000 |
| Net (loss)/income | NaN | NaN | NaN | -15,538,900 |
| Accounts receivable, net and other receivables | 648,568 | -650,106 | -1,191,732 | 1,478,433 |
| Prepaid expenses and other current assets | 46,801 | 2,996 | 2,878 | -45,204 |
| Accounts payable and accrued liabilities | -184,201 | 657,831 | -528,708 | -965,708 |
| Accrued compensation and benefits | 96,248 | -59,859 | NaN | NaN |
| Amortization of software development costs | NaN | NaN | NaN | 17,083 |
| Accrued interest payable | 138,254 | -119,946 | NaN | NaN |
| Net cash used in operating activities | -2,889,834 | -3,314,438 | -2,468,797 | -6,303,122 |
| Cash acquired on business combination | 0 | 0 | 0 | 34,983 |
| Release of trust account to companys bank account | NaN | NaN | NaN | 833,324 |
| Cash withdrawn from trust account in connection with redemption | NaN | NaN | NaN | 1,001,216 |
| Issuance of promissory notes | NaN | 0 | 0 | 0 |
| Capitalized software development costs | 129,000 | 187,000 | 94,000 | 174,000 |
| Proceeds from private placement | NaN | 4,780,021 | 0 | 0 |
| Cash withdrawn from trust account in connection with redemption | 0 | 0 | 1,001,216 | NaN |
| Proceeds from capital raise | NaN | 1,109,104 | 5,609,080 | 265,504 |
| Release of trust account to company's bank account | 0 | 0 | 833,324 | NaN |
| Proceeds from notes payable | NaN | NaN | NaN | 513,200 |
| Net cash (used in)/provided by investing activities | -129,000 | -187,000 | -94,000 | 1,695,523 |
| Proceeds from exercise of warrants | 167 | 0 | 200 | 3,664,671 |
| Proceeds from revolving line of credit | NaN | 0 | NaN | NaN |
| Redemption of common stock subject to redemption | 0 | 0 | 1,001,216 | NaN |
| Repayments of revolving line of credit | 207,850 | 315,671 | NaN | NaN |
| Net proceeds from line of credit | NaN | NaN | -18,000 | NaN |
| Proceeds from bank borrowings | NaN | 0 | NaN | NaN |
| Repayment of bank borrowings | 0 | 276,012 | 344,066 | 155,114 |
| Repayment of loans payable | NaN | 210,843 | NaN | NaN |
| Proceeds from convertible notes payable | 0 | 0 | 2,376,500 | NaN |
| Proceeds from notes payable | 0 | 0 | 513,200 | NaN |
| Redemption of common stock subject to redemption | NaN | NaN | NaN | -1,001,216 |
| Proceeds from notes payable-Related Party | NaN | 0 | 0 | NaN |
| Net proceeds from line of credit | NaN | NaN | NaN | -12,900 |
| Repayments of notes payable-Related Party | NaN | 0 | 27,500 | NaN |
| Proceeds from convertible notes payable | NaN | NaN | NaN | 2,376,500 |
| Repayments of notes payable-Nonrelated Party | NaN | 0 | 101,579 | NaN |
| Repayments of notes payable | -70,000 | NaN | NaN | 70,000 |
| Net cash (used in)/provided by financing activities | -207,683 | 5,104,599 | 5,201,035 | 5,580,645 |
| Net (decrease)/increase in cash and cash equivalents | -3,226,517 | 1,603,161 | 2,638,238 | 973,046 |
| Cash and cash equivalents, beginning of period | 5,255,235 | 3,652,074 | 40,790 | NaN |
| Cash and cash equivalents, end of period | 2,028,718 | 5,255,235 | 3,652,074 | NaN |